Infant formula sales slump at Biostime but firm bullish over future growth

Sales at Chinese infant nutrition firm Biostime dropped by 14% in the first half of 2016 to RMB1.46bn (US$220m), with the Biostime brand – which accounts for 86% of the company’s sales – down 5.4% and the value brand Adimil down 65.7%.

Read more about it via http://bit.ly/2bL9pcy